Literature DB >> 8032046

Circulating markers of free radical activity in patients with pulmonary tuberculosis.

C I Jack1, M J Jackson, C R Hind.   

Abstract

SETTING: Toxic free radicals have been implicated in the development of lung fibrosis which may be a long-term sequela of pulmonary tuberculosis.
OBJECTIVE: To measure circulating indicators of free radical activity in patients with pulmonary tuberculosis in order to determine whether patients with active pulmonary TB have elevated levels of circulating free radical activity, and whether these levels correlated with disease activity as determined by other blood markers of inflammation.
DESIGN: 17 patients with active pulmonary tuberculosis were studied. Serial serum levels of 3 assays of free radical activity were measured at diagnosis (17 patients), and over a 2-7 month period on chemotherapy (8 patients). 3 patients with active lymph node tuberculosis were also studied and 4 patients with old lung scarring from previously treated tuberculosis had their serum markers analysed.
RESULTS: All 3 serum markers of free radical activity were elevated in patients with active pulmonary tuberculosis. During serial measurement in 8 patients the % molar ratio of 9,11 linoleic acid/9,12 linoleic acid fell progressively with treatment. Thiobarbituric acid reactive substances (TBARS) were initially elevated in 6/8 patients and remained elevated despite treatment. In 2 patients TBARS were in the normal range at presentation but subsequently rose with treatment. Desferrioxamine-chelatable iron was initially normal in all but 1 patient, remained normal in 2 patients, rose in 4 patients and fell in 1 patient.
CONCLUSIONS: These results suggest that increased circulating levels of free radical activity are found in active pulmonary tuberculosis and hence may play a role in the resultant fibrosis. It also reinforces the belief that a range of free radical activity (FRA) indicators are produced in any inflammatory process with fibrogenic potential and that these indicators may be measuring different stages of the disease process.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8032046     DOI: 10.1016/0962-8479(94)90042-6

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  18 in total

Review 1.  Fluorescent probe ABM and estimation of immune state in patients with different pathologies (review article).

Authors:  Inta Kalnina; Ruta Bruvere; Tija Zvagule; Natalija Gabruseva; Laura Klimkane; Elena Kirilova; Imants Meirovics; Gunta Kizane
Journal:  J Fluoresc       Date:  2009-08-01       Impact factor: 2.217

2.  Antioxidant status, C-reactive protein and iron status in patients with pulmonary tuberculosis.

Authors:  Dhia A Taha; Imad A-J Thanoon
Journal:  Sultan Qaboos Univ Med J       Date:  2010-11-14

3.  Effects of treatment on free radicals in patients with pulmonary tuberculosis in South Western Nigeria.

Authors:  Wasiu Olalekan Adebimpe; Ayodeji Oluwaseun Faremi; Sulaiman Adebayo Nassar
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

4.  Reactive oxygen metabolites can be used to differentiate malignant and non-malignant pleural efffusions.

Authors:  Ufuk Cobanoglu; Fuat Sayir; Duygu Mergan
Journal:  Ann Thorac Med       Date:  2010-07       Impact factor: 2.219

5.  Effect of vitamin A and vitamin C supplementation on oxidative stress in HIV and HIV-TB co-infection at Lagos University Teaching Hospital (LUTH) Nigeria.

Authors:  Oluwamayowa Makinde; Kunle Rotimi; Victor Ikumawoyi; Titilope Adeyemo; Sunday Olayemi
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

6.  Increased expression of host iron-binding proteins precedes iron accumulation and calcification of primary lung lesions in experimental tuberculosis in the guinea pig.

Authors:  Randall J Basaraba; Helle Bielefeldt-Ohmann; Ellie K Eschelbach; Claire Reisenhauer; Airn E Tolnay; Lauren C Taraba; Crystal A Shanley; Erin A Smith; Cathy L Bedwell; Elizabeth A Chlipala; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2007-10-17       Impact factor: 3.131

7.  Oxidative Stress Markers in Tuberculosis and HIV/TB Co-Infection.

Authors:  Shreewardhan Haribhau Rajopadhye; Sandeepan R Mukherjee; Abhay S Chowdhary; Sucheta P Dandekar
Journal:  J Clin Diagn Res       Date:  2017-08-01

8.  Biomarkers of oxidative stress and personalized treatment of pulmonary tuberculosis: emerging role of gamma-glutamyltransferase.

Authors:  Etienne Mokondjimobe; Benjamin Longo-Mbenza; Jean Akiana; Ulrich Oswald Ndalla; Regis Dossou-Yovo; Joseph Mboussa; Henri-Joseph Parra
Journal:  Adv Pharmacol Sci       Date:  2012-05-07

9.  The perils of laboratory research.

Authors:  Feisal A Al-Kassimi; Muhammad A Chishi
Journal:  Ann Thorac Med       Date:  2011-04       Impact factor: 2.219

Review 10.  Co-infections as Modulators of Disease Outcome: Minor Players or Major Players?

Authors:  Priti Devi; Azka Khan; Partha Chattopadhyay; Priyanka Mehta; Shweta Sahni; Sachin Sharma; Rajesh Pandey
Journal:  Front Microbiol       Date:  2021-07-06       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.